FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)

PMA: P010031 · Supplement: S893 · Decision Jun 18, 2025
Classifications
1
FEI Numbers
26
Registration Numbers
26

Basic Information

Device Name
Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
Trade Name
Amplia MRI CRT-D DTMB1D1, DTMB1D4; Amplia MRI Quad CRT-D DTMB1Q1, DTMB1QQ; Brava CRT-D DTBC1D4; Brava CRT-D DTBC1D1; Bra
PMA Number
P010031
Supplement Number
S893
Device Class
FDA Class 3
Product Code
NIK
Generic Name
Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D)
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
June 18, 2025
Date Received
May 30, 2025
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

updates to the mid-process visual inspection criteria for hybrid components

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NIK Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)